Eli Lilly and Company – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Third party tender offer – amended

Prospectus for primary offering

Free writing prospectus

Prospectus for primary offering

Third party tender offer – amended

Ownership Filter

Sulzberger Gabrielle

Johnson Kimberly H

Hedley Mary Lynne

News Filter

Lilly Announces Changes on Board of Directors

Lilly Reports Q3 2024 Financial Results Highlighted by Strong Volume-Driven Revenue Growth From New Products

For Release: Immediately

Lilly Announces Retirement of Marschall S. Runge From Its Board of Directors

Other Events, Financial Statements or Exhibits

Proxies Filter

Letter to shareholders

Letter to shareholders

Letter to shareholders

Letter to shareholders

Letter to shareholders

Other Filter

Conflict Minerals disclosure

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC